| 1 |
35125086 | Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling. | 2022 |
1 |
| 2 |
33272980 | A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer. | 2021 Feb 15 |
1 |
| 3 |
33767994 | Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study. | 2021 |
1 |
| 4 |
33910628 | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report. | 2021 Apr 29 |
2 |
| 5 |
28096479 | IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells. | 2017 Apr |
2 |
| 6 |
26690777 | GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells. | 2016 Feb 15 |
1 |
| 7 |
26199431 | Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes. | 2015 Oct |
2 |
| 8 |
23459444 | Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen. | 2014 Feb |
1 |
| 9 |
24243064 | Tamoxifen as a therapeutic agent in acromegaly. | 2014 Dec |
2 |
| 10 |
25304297 | Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens. | 2014 Nov |
2 |
| 11 |
21221819 | Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotide. | 2012 Dec |
2 |
| 12 |
22319035 | Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. | 2012 Apr |
2 |
| 13 |
22429491 | Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim. | 2012 Mar 19 |
2 |
| 14 |
21263044 | IGF1 and risk of additional breast cancer in the WHEL study. | 2011 Apr |
4 |
| 15 |
21273576 | Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer. | 2011 Jan |
5 |
| 16 |
21595894 | Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. | 2011 May 19 |
1 |
| 17 |
21908557 | A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. | 2011 Nov 1 |
1 |
| 18 |
22046442 | Sensitization of glioma cells to tamoxifen-induced apoptosis by Pl3-kinase inhibitor through the GSK-3β/β-catenin signaling pathway. | 2011 |
1 |
| 19 |
20444909 | Paracrine regulation of growth hormone secretion by estrogen in women. | 2010 Aug |
2 |
| 20 |
20843951 | Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men. | 2010 Dec |
4 |
| 21 |
21472336 | Combination of tamoxifen and antisense human telomerase RNA inhibits glioma cell proliferation and anti-apoptosis via suppression of telomerase activity. | 2010 Nov-Dec |
1 |
| 22 |
19597031 | Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. | 2009 Aug 10 |
1 |
| 23 |
17709798 | Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. | 2007 Sep 20 |
1 |
| 24 |
18000226 | Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway. | 2007 Oct |
1 |
| 25 |
16382122 | Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women. | 2006 Jan 1 |
2 |
| 26 |
16847815 | Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients. | 2006 Apr-Jun |
2 |
| 27 |
15809018 | Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486). | 2005 Apr |
1 |
| 28 |
15072444 | Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells. | 2004 Mar-Apr |
1 |
| 29 |
15080777 | Raloxifene decreases serum IGF-I in male patients with active acromegaly. | 2004 Apr |
1 |
| 30 |
15223841 | Comparison of tamoxifen and testosterone propionate in male rats: differential prevention of orchidectomy effects on sex organs, bone mass, growth, and the growth hormone-IGF-I axis. | 2004 Jul-Aug |
1 |
| 31 |
15579914 | Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. | 2004 |
1 |
| 32 |
15762036 | Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures. | 2004 Nov |
1 |
| 33 |
12656665 | Raloxifene lowers IGF-I levels in acromegalic women. | 2003 Apr |
1 |
| 34 |
12680157 | Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. | 2003 Jan-Feb |
2 |
| 35 |
12699704 | A low-fat, whole-food vegan diet, as well as other strategies that down-regulate IGF-I activity, may slow the human aging process. | 2003 Jun |
1 |
| 36 |
12777179 | Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus. | 2003 May 7 |
1 |
| 37 |
12783932 | A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. | 2003 Jun 4 |
1 |
| 38 |
12926118 | Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients. | 2003 May-Jun |
3 |
| 39 |
11844826 | Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer. | 2002 Feb 15 |
1 |
| 40 |
12490847 | Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism. | 2002 Dec |
2 |
| 41 |
11299809 | Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients. | 2001 Jan-Feb |
6 |
| 42 |
11535549 | Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial. | 2001 Sep |
1 |
| 43 |
11577172 | IGF status is altered by tamoxifen in patients with breast cancer. | 2001 Oct |
2 |
| 44 |
11759825 | Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. | 2001 Sep |
3 |
| 45 |
10762020 | Chemoprevention of breast cancer: the Italian experience. | 2000 |
1 |
| 46 |
10848871 | Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. | 2000 Jun |
2 |
| 47 |
10940491 | Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. | 2000 Jul 25 |
4 |
| 48 |
10940495 | Effect of tamoxifen treatment on the endometrial expression of human insulin-like growth factors and their receptor mRNAs. | 2000 Jul 25 |
5 |
| 49 |
28796357 | Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. | 2000 Jun |
2 |
| 50 |
10189133 | A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. | 1999 Mar 15 |
1 |